Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
-
Elevating Crypto Promotions: CryptoVirally Rolls Out New Offers and Cointelegraph Enhancements
-
Disclosure of total number of voting rights and number of shares in the capital at December 31, 2023
-
DSM: Net Asset Value(s)
-
FACTBLOCK Joins WEMIX3.0 Mainnet’s Node Council Partners as WONDER 13
-
Goliath Finds 101 g/t Au (3.25 oz/t) At Newly Discovered Full Contact Outcrop Within 1.4 km Gossan Trend On Golddigger’s Cambria Ice Fields, Golden Triangle, British Columbia
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
Kraig Biocraft Laboratories Targets Vertical Markets for its Spider Silk and Shares Planned Applications
-
SitePro™ Rentals Opens in Shreveport, Continues Construction Equipment Expansion in Louisiana
-
Trawick International’s Bailey Foster Promoted to Senior Vice President, Travel Insurance
-
Novo Nordisk A/S - share repurchase programme
-
Xanadu Enters into New Magmatic Copper and Nickel Sulphide Project
-
Brunswick Exploration Starts Winter Drilling Campaign at Mirage
-
Top Web3-native game studio Maniac Panda Games to launch groundbreaking TCG “Underground Waifus” on WEMIX PLAY
-
Condor Receives Feedgas Allocation for Its LNG Project in Kazakhstan
-
Western Metallica Makes Copper Discovery on Caña Brava Porphyry Project in Peru
-
Canada says that 85% of the TRC Calls to Action are either complete or well under way. Indigenous Watchdog says, “Really?”
-
Talisker Intersects 28.58 g/t Au over 6.35 Metres from the Bralorne Gold Project Resource Conversion Program
-
Regrow Selected as Independent Verifier for Mekong River Delta Emissions Reduction Initiative in Rice Production
-
Mercury Introduces Direct RF System-On-Module Powered by Intel Agilex FPGA
-
Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resource Capabilities in Support of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
-
Lightbridge Announces Upcoming Industry Event and Media Interview
-
ASTEC Appoints Two New Members to Board of Directors, One Director Retiring
-
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
-
Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
-
Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leuke
-
ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
-
Beneficient Closes Initial Series of Liquidity Transaction Financings of Limited Partner Interests Sourced Through Preferred Liquidity Provider Program (“PLP Program”)
-
Solaris Commences 2024 Drilling Program at Warintza Project
-
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
-
Dorman rolls into 2024 with more than 300 new products, including more aftermarket exclusives and Dorman® OE FIX™ innovations
-
Power Solutions International (PSI) Showcases Engines at PowerGen Trade Show
-
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
-
NMD Pharma Appoints Morten Bull as SVP, General Counsel and Head of People & Business Services
-
ProteinLogic and Stellenbosch University receive $1.3 million grant to develop blood test to monitor response to TB antimicrobial chemotherapy
-
NMD Pharma Appoints Morten Bull as SVP, General Counsel and Head of People & Business Services
-
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that ChargePoint Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CHPT
-
Madison Metals Provides Update for its Uranium Forward Sales Agreement with Sanmiguel Capital Investment
-
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
-
Form 8.3 - Wincanton
-
W&T Offshore Announces Closing of Accretive Acquisition of Six Gulf of Mexico Fields
-
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer
-
Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient
-
Park Hotels & Resorts Provides Preliminary Q4 2023 and Full-Year 2023 Results
-
Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
-
Radisson Intersects 81.83 g/t Gold Over 3.00 Metres on First Holes of its Phase 1 Drill Program at its O’Brien Gold Project in Quebec, Canada
-
TRX Gold Corporation Announces Ticker Symbol Change on the Toronto Stock Exchange to “TRX”
-
Auction result of Treasury Bills - RIKV 24 0320 - RIKV 24 0619
-
H World Group Limited Announces Preliminary Results for Hotel Operations in the Fourth Quarter and the Full Year of 2023
-
Fingerprint Cards AB (publ) announces price and number of new shares in connection with the second scheduled amortisation and interest payment under its outstanding convertible bonds
